ROMIPLOSTIM News
ROMIPLOSTIM currently has 0 news articles, with 13 predicted indications.
This page combines the AI-predicted indications for ROMIPLOSTIM with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (13):
- aplastic anemia (99.0%)
- autoimmune thrombocytopenic (99.0%)
- idiopathic aplastic anemia (99.0%)
- primary release disorder of platelets (100.0%)
- pseudo-von Willebrand disease (100.0%)
- Glanzmann thrombasthenia (100.0%)
- fetal and neonatal alloimmune thrombocytopenia (100.0%)
- Scott syndrome (100.0%)
- hemorrhagic disorder due to a constitutional thrombocytopenia (100.0%)
- bleeding diathesis due to a collagen receptor defect (100.0%)
- platelet-type bleeding disorder (99.9%)
- autosomal dominant macrothrombocytopenia (99.9%)
- Ehlers-Danlos syndrome, fibronectinemic type (99.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.